Lamivudine-Zidovudine-Nevirapine

What is Lamivudine-Zidovudine-Nevirapine?

Lamivudine-zidovudine-nevirapine is a fixed-dose combination antiretroviral medication used to treat HIV-1 infection. It combines three active ingredients from two different drug classes: lamivudine and zidovudine, which are nucleoside reverse transcriptase inhibitors (NRTIs), and nevirapine, which is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Together, these three agents form a complete antiretroviral regimen in one tablet.

Common approved uses include:

• Treatment of HIV-1 infection in adults and eligible pediatric patients, as a complete triple-drug regimen

Available formulation:

• Oral tablet (fixed-dose combination, commonly 150 mg lamivudine / 300 mg zidovudine / 200 mg nevirapine)

This medication does not cure HIV. It works to suppress viral replication and support immune function when taken consistently and exactly as prescribed.

What is the Recommended Dosage of Lamivudine-Zidovudine-Nevirapine?

Dosage is determined by an infectious disease specialist or HIV care provider and depends on:

• Patient age and body weight
• Kidney and liver function
• Whether the patient is newly starting nevirapine (which often requires a lead-in dosing period to reduce rash risk)
• Other medications used in the treatment plan

Available dosage form: Fixed-dose combination oral tablet, typically taken twice daily.

Because nevirapine often requires a gradual dose introduction and ongoing monitoring, patients must follow their specialist’s exact instructions and never adjust dosing independently.

How Lamivudine-Zidovudine-Nevirapine Works

This combination medication uses two different mechanisms to block HIV replication:

• Lamivudine and zidovudine (NRTIs) interfere with the reverse transcriptase enzyme by acting as faulty building blocks, stopping the virus from copying its genetic material.
• Nevirapine (an NNRTI) binds directly to the reverse transcriptase enzyme at a different site, blocking its function through a separate chemical pathway.

Using drugs from two different classes together helps reduce the likelihood of the virus developing resistance and provides more complete viral suppression than a single class alone. This medication manages HIV infection but does not eliminate it from the body.

Is a Prescription Required to Buy Lamivudine-Zidovudine-Nevirapine Online?

Yes. This is a prescription-only medication that requires ongoing medical supervision.

Patients should consult with:

• An infectious disease specialist or HIV care provider, who can guide dose initiation, monitor for side effects, and adjust the treatment plan as needed

Important safety notes:

• Purchase only from a licensed pharmacy requiring a valid prescription
• Avoid unregulated online sellers, as counterfeit antiretroviral medications carry serious health risks
• Never substitute veterinary or non-human formulations of any medication

Side Effects of Lamivudine-Zidovudine-Nevirapine

Common Side Effects

• Headache
• Nausea
• Fatigue
• Diarrhea
• Muscle aches
• Mild skin rash
• Loss of appetite

Serious Side Effects

• Severe skin reactions, including rash accompanied by fever, blistering, or mucous membrane involvement, which require immediate medical attention
• Signs of liver problems (yellowing of skin or eyes, dark urine, severe fatigue, right-sided abdominal pain) — nevirapine carries a specific risk of serious, potentially life-threatening liver toxicity, especially during the first weeks of treatment
• Signs of bone marrow suppression, such as unusual bruising, bleeding, or persistent weakness
• Symptoms of lactic acidosis (rapid breathing, unusual muscle pain, stomach discomfort, feeling unusually cold)
• Signs of a severe allergic reaction (facial or throat swelling, difficulty breathing)

Because of the risk of serious liver toxicity and severe skin reactions, close medical monitoring is especially important during the first several weeks of treatment. Any new or worsening rash, fever, or signs of liver problems should be reported to a specialist immediately.

Drug Interactions

Nevirapine is processed by the liver and can interact with a wide range of medications. Categories that may interact include:

• Other medications metabolized by the liver’s enzyme systems, including certain antibiotics, antifungals, and antiviral medications
• Hormonal contraceptives, which may become less effective
• Medications affecting bone marrow or kidney function
• Over-the-counter pain relievers, particularly those affecting the liver
• Herbal supplements, including St. John’s Wort, which can significantly reduce the effectiveness of this medication

Patients should give their licensed medical specialist a complete list of all prescription medications, over-the-counter drugs, vitamins, and herbal supplements before starting treatment.

Safety & Important Considerations

• Liver disease precautions: This medication carries specific warnings about serious liver toxicity; patients with pre-existing liver conditions require close monitoring, and liver function tests are typically performed regularly, especially early in treatment.
• Kidney conditions: Dose adjustments may be needed for patients with reduced kidney function.
• Pregnancy and breastfeeding: Any decisions about antiretroviral therapy during pregnancy or breastfeeding should be made individually with a specialist, weighing risks and benefits.
• Age-related considerations: Dosing and monitoring may differ for pediatric and elderly patients.
• Monitoring requirements: Regular blood tests for liver function, blood cell counts, and viral load are an essential part of treatment.
• FDA safety warnings: This medication carries warnings regarding severe, life-threatening skin reactions and liver toxicity; patients should be counseled on early warning signs before starting treatment.

Who This Medication Is For

This medication is generally prescribed for individuals diagnosed with HIV-1 infection who require a complete triple-drug antiretroviral regimen in a simplified, combined tablet form. It is used as part of an individualized treatment plan established by an HIV specialist based on viral load, immune status, and overall health.

Who Should Not Take Lamivudine-Zidovudine-Nevirapine

This medication may not be appropriate for individuals who:

• Have a known hypersensitivity to lamivudine, zidovudine, nevirapine, or related components
• Have moderate to severe liver impairment or significant liver disease
• Have severe bone marrow suppression or very low blood cell counts
• Have previously experienced a severe reaction to nevirapine or similar medications

A full medical history and liver function assessment by a licensed specialist is necessary before starting treatment to rule out contraindications.

What to Do If You Miss a Dose

If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular schedule.

Do not double the dose to make up for a missed one. Consistent dosing is essential for this medication’s effectiveness and to reduce the risk of drug resistance. Contact a licensed medical specialist if doses are missed frequently or if there is uncertainty about how to proceed.

Related medications to Lamivudine-Zidovudine-Nevirapine

This fixed-dose product contains lamivudine, zidovudine, and nevirapine. Related pages include Lamivudine, Zidovudine, and Lamivudine-Zidovudine. The complete regimen and individual clinical factors determine appropriate antiretroviral treatment.

Storage Instructions

• Store at room temperature, away from excessive heat or cold
• Keep in the original container, protected from moisture and light
• Keep out of reach of children and pets
• Do not use expired medication

Disclaimer:

This page is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Patients must consult a licensed infectious disease specialist or qualified healthcare provider before starting, changing, or stopping this medication. Treatment decisions must be based on a full clinical evaluation by a qualified specialist.